Data Tables

View HTML		View PDF
Section XII
12.1a	Waiting List Patient Characteristics at End of Year Lung Waiting List Active Waitlist Patients, 1995 to 2004	(43 k)
	Age
	Blood Type
	Residency
	Diagnosis
	Gender
	Previous Transplant Any Organ
	Race
	Previous Transplant Same Organ
	Time on Waiting List
12.1b	Waiting List Patient Characteristics at End of Year Lung Waiting List Active and Inactive Patient Comparison, 2000 to 2004	(37 k)
	Age
	Diagnosis
	Gender
	Race
	Time on Waiting List
12.2	Time to Transplant, 1995 to 2004 New Lung Waiting List Registrations	(55 k)
	Blood Type
	Age
	Gender
	All Patient Types
	Previous Transplant Any Organ
	Race
	Residency
12.3	Reported Deaths and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2004 Lung Waiting List	(41 k)
	Age
	Blood Type
	Gender
	Race
12.4a	Transplant Recipient Characteristics, 1995 to 2004 Recipients of Deceased Donor Lungs	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Diagnosis
	Cold Ischemia Time
	On Life Support at TX
	Hospitalized at Transplant
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
	Procedure Type
12.4b	Transplant Recipient Characteristics, 1995 to 2004 Recipients of Living Donor Lungs	(46 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Donor Relation
	Diagnosis
	On Life Support at TX
	Hospitalized at Transplant
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Payment Source
	Procedure Type
12.5	Incidence of Transplant, 1995 to 2004 Lung Transplants per 1 Million Population	(29 k)
12.6a	Immunosuppression Use for Induction, 1995 to 2004 Recipients with Lung Transplants	(30 k)
12.6b	Immunosuppression Use for Induction by Discharge Regimen, 2000 to 2004 Recipients with Lung Transplants	(32 k)
12.6c	Immunosuppression Use for Induction by Steroid Use at Discharge, 2000 to 2004 Recipients with Lung Transplants	(29 k)
12.6d	Immunosuppression Use for Maintenance by Regimen Prior to Discharge, 1995 to 2004 Recipients with Lung Transplants	(30 k)
12.6e	Immunosuppression Use for Maintenance Prior to Discharge, 1995 to 2004 Recipients with Lung Transplants	(32 k)
12.6f	Immunosuppression Use for Maintenance by Regimen One Year Following Transplantation, 1994 to 2003 Recipients with Lung Transplants	(32 k)
12.6g	Immunosuppression Use for Maintenance Between Discharge and One Year Following Transplantation, 1994 to 2003 Recipients with Lung Transplants	(32 k)
12.6h	Persistency of Discharge Regimen by Follow-up Period, 1999 to 2003 Recipients with Lung Transplants	(34 k)
12.6i	Immunosuppression Use for Antirejection Treatment from Transplant to One Year Following Transplantation, 1994 to 2003 Recipients with Lung Transplants	(30 k)
12.7a	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2003 Rates for Recipients during First Year after Deceased Donor Lung Transplantation	(71 k)
	Blood Type
	Residency
	Gender
	Race
	Age of Donor
	Procedure Type
	Age
	Cold Ischemia Time
	On Life Support at TX
	Hospitalized at Transplant
	Previous Transplant Any Organ
	Diagnosis
12.7b	Patients and Annual Death Rates Per 1,000 Patient-Years at Risk, 1995 to 2003 Rates for Recipients during First Year after Living Donor Lung Transplantation	(64 k)
	Blood Type
	Residency
	Gender
	Race
	Age of Donor
	Procedure Type
	Age
	On Life Support at TX
	Hospitalized at Transplant
	Previous Transplant
	Diagnosis
12.8	Adjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Gender
	Race
	Diagnosis
12.9a	Unadjusted Graft Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(43 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Age of Donor
	Previous Transplant Same Organ
	Procedure Type
	Diagnosis
	Cold Ischemia Time
	On Life Support at TX
	Hospitalized at Transplant
12.9b	Unadjusted Graft Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(42 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Relation
	Age of Donor
	Previous Transplant Same Organ
	Diagnosis
	On Life Support at TX
	Hospitalized at Transplant
12.10a	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Deceased Donor Lung Transplants	(29 k)
12.10b	Unadjusted Graft Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Living Donor Lung Transplants	(29 k)
12.11	Adjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(37 k)
	Age
	Gender
	Race
	Diagnosis
12.12a	Unadjusted Patient Survival, Deceased Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(43 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Age of Donor
	Procedure Type
	Diagnosis
	Cold Ischemia Time
	On Life Support at TX
	Hospitalized at Transplant
12.12b	Unadjusted Patient Survival, Living Donor Lung Transplants Survival at 3 Months, 1 Year, 3 Years, and 5 Years	(42 k)
	Age
	Blood Type
	Residency
	Gender
	Race
	Center Volume
	Donor Relation
	Age of Donor
	Diagnosis
	On Life Support at TX
	Hospitalized at Transplant
12.13a	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Deceased Donor Lung Transplants	(29 k)
12.13b	Unadjusted Patient Survival by Year of Transplant at 3 Months, 1 Year, 3 Years, and 5 Years Living Donor Lung Transplants	(29 k)
12.14	Prevalence of People Living with a Functioning Transplant at End of Year Lung Recipients, 1995 to 2004	(44 k)
	Blood Type
	Residency
	Gender
	Race
	Age
	Diagnosis
	On Life Support at TX
	Hospitalized at Transplant
	Previous Transplant Same Organ
	Previous Transplant Any Organ
	Procedure Type
12.15	Transplants by State and Transplant Center, 1995 to 2004 Lung	(55 k)